Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3110215 | 0.77 | MAPT (0.53) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL14922152 | 0.75 | MAPT (0.55) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL3121156 | 0.75 | MAPT (0.59) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL8330270 | 0.74 | MAPT (0.68) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL13989240 | 0.74 | MAPT (0.52) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL5367260 | 0.74 | MAPT (0.51) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL13950835 | 0.72 | TXN (0.64) | MAPTHTTNPSR1SMN1; SMN2ALDH1A1 | |
| SCHEMBL13989219 | 0.71 | MAPT (0.41) | MAPTHTTNPSR1SMN1; SMN2MEN1 | |
| SCHEMBL28968730 | 0.70 | MEN1 (0.61) | MAPTHTTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL26664476 | 0.69 | BLM (0.52) | MAPTSMN1; SMN2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200104-B2 | Polymer | WARWICK EFFECT POLYMERS LIMITED (GB) | 2015-12-01 | — | — | US | disclosed |
| US-20130295040-A1 | POLYMER | WARWICK EFFECT POLYMERS LTD (US) | 2013-11-07 | — | — | US | disclosed |
| US-8436104-B2 | Polymer | WARWICK EFFECT POLYMERS LIMITED (GB) | 2013-05-07 | — | — | US | disclosed |
| US-20080300348-A1 | Polymer | WARWICK EFFECT POLYMERS LIMITED | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130295040-A1 | POLYMER | PCNA, PARG, COASY | MAPT 3594/4885HTT 3788/4885NPSR1 4546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.